ZINPLAVA 25 mg / mL concentrate for solution for infusion
- Licence status
- Withdrawn: 28/09/2026
- Active substances
- Bezlotoxumab
- Dosage Form
- Concentrate for solution for infusion
- Licence number
- EU/1/16/1156/001
- Licence holder
- Merck Sharp & Dohme BV
Product documents
Licence information
- ATC code
- J06BB Specific immunoglobulins, J06BB21 Bexlooxumab
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued
- 18/01/2017